MR. DAN CRIPPEN

Lobbying for AMGEN · Manufacture Pharmaceuticals

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · $36,000.00 income · posted Oct 1, 2025

Lobbying activity 3

Pharmacy

pharmacy rebates and discounts pharmacy R&D

Economics/Economic Development

pharmacy rebates and discounts

Government Issues

congressional procedure

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.